Trodusquemine Completed Phase 1 Trials for BMI >30 kg/m2 Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00509132A Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers